WearOptimo is a groundbreaking brand based in Brisbane, Australia, established in 2018 by Professor Mark Kendall. With a focus on revolutionizing healthcare, their team comprises exceptional talent from around the world. Their mission is to address today's greatest healthcare challenges with practical and affordable wearable technology that allows individuals to access their health signals when time matters most.

Drawing upon their team's extensive experience in developing minimally invasive medical devices, WearOptimo is at the forefront of the global wearables revolution. Their patented Microwearable monitoring sensors are designed to read and interpret key health signals within the skin, offering continuous monitoring in precision health. Led by Professor Mark Kendall, their world-class team has over 25 years of experience in building successful healthcare businesses and has created more than $2 billion of value for investors.

They are supported by key investors such as the Australian National University and Aspen Medical, as well as securing several million dollars in equity investment and non-dilutive grant support from the Australian Federal Government and Queensland State Government. Partnering with global provider Aspen Medical, WearOptimo has already introduced their first product, the Hydration monitoring sensor, which benefits from established distribution channels. Additionally, they boast a strong suite of intellectual property.

With their high-performance, interdisciplinary team, WearOptimo is committed to tackling crucial healthcare challenges with practical solutions. Supported by the Australian National University, WearOptimo aims to commercialize Australian intellectual property and build a national asset that all Australians can be proud of. Situated in Brisbane, Queensland, their premises serve as the hub for their innovative work.

For any inquiries, they can be reached at +61 7 3517 8000 or info@wearoptimo. com